Endometriosis and assisted reproductive technologies: are outcomes affected?
The preponderance of recent data suggests that endometriosis does not adversely affect in-vitro fertilization pregnancy rates. However, many studies demonstrate impaired oocyte quality, decreased fertilization, and compromised implantation rates. Such findings give insight into the mechanisms by which endometriosis may impact on fertility, and provide clues as how to focus assisted reproductive technologies in order to overcome these deficiencies. Specifically, extended downregulation protocols, ample use of gonadotropins for ovarian stimulation, and conservative management of endometriomas have all been suggested as means to optimize in-vitro fertilization outcomes for women with endometriosis.
Mahutte
N G
NG
Department of Obstetrics and Gynecology, Yale University, New Haven, Connecticut 06520-8063, USA.
Arici
A
A
D004715:Endometriosis / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology*; D005260:Female; D006062:Gonadotropins / Q000627:therapeutic use; D006801:Humans; D007247:Infertility, Female / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D017063:Outcome Assessment, Health Care; D011247:Pregnancy; D012099:Reproductive Techniques
D006062:Gonadotropins